Janssen Pharmaceuticals Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Janssen Pharmaceuticals Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010909
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a healthcare products provider that offers various medicines. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental health, neurologics, pain management, women’s health, and among others. It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer’s disease, epilepsy, migraine prevention and treatment. The company sells its products through a network of distributors across the US. Janssen is headquartered in Titusville, New Jersey, the US.

Janssen Pharmaceuticals Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Janssen Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Janssen Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Janssen Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Janssen Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Janssen Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Janssen Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Partnerships 10
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 10
Genomic Health Enters into Research Agreement with Janssen Pharma 11
Karolinska Institutet Partners with Johnson & Johnson Companies 12
Janssen Pharma Enters into Agreement with Cue 13
Janssen Pharmaceuticals Inc – Key Competitors 14
Janssen Pharmaceuticals Inc – Key Employees 15
Janssen Pharmaceuticals Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Janssen Pharmaceuticals Inc, Medical Equipment, Key Facts 2
Janssen Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Janssen Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Janssen Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Janssen Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Janssen Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Janssen Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 10
Genomic Health Enters into Research Agreement with Janssen Pharma 11
Karolinska Institutet Partners with Johnson & Johnson Companies 12
Janssen Pharma Enters into Agreement with Cue 13
Janssen Pharmaceuticals Inc, Key Competitors 14
Janssen Pharmaceuticals Inc, Key Employees 15
Janssen Pharmaceuticals Inc, Other Locations 16
Janssen Pharmaceuticals Inc, Subsidiaries 16

★海外企業調査レポート[Janssen Pharmaceuticals Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ANS Group Plc:企業の戦略的SWOT分析
    ANS Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • TripAdvisor Inc:企業の戦略・SWOT・財務分析
    TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report Summary TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • American Water Works Company, Inc.:企業の戦略・SWOT・財務情報
    American Water Works Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Water Works Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Sinofert Holdings Ltd (297):企業の財務・戦略的SWOT分析
    Sinofert Holdings Ltd (297) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SAS AB:戦略・SWOT・企業財務分析
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Regen BioPharma Inc (RGBP):企業の財務・戦略的SWOT分析
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • Applied DNA Sciences Inc (APDN):企業の財務・戦略的SWOT分析
    Summary Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company’s products comprise DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DNA se …
  • Becker Avionics, Inc.:企業の戦略・SWOT・財務情報
    Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Becker Avionics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Movenpick Schweiz AG:企業の戦略・SWOT・財務情報
    Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report Summary Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Providence Resources plc (PZQA):企業の財務・戦略的SWOT分析
    Summary Providence Resources Plc (Providence Resource) is an upstream oil and gas exploration and development company that explores and develops hydrocarbon assets. The company's areas of operations include Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's basin an …
  • Arch Capital Group Ltd.:企業の戦略・SWOT・財務情報
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kimball International Inc (KBAL):企業の財務・戦略的SWOT分析
    Kimball International Inc (KBAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Median Technologies SA (ALMDT):医療機器:M&Aディール及び事業提携情報
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • W.W. Grainger Inc (GWW):企業の財務・戦略的SWOT分析
    W.W. Grainger Inc (GWW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …
  • Interglobe Aviation Limited:戦略・SWOT・企業財務分析
    Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Delfi Limited:企業の戦略・SWOT・財務情報
    Delfi Limited - Strategy, SWOT and Corporate Finance Report Summary Delfi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Complexa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complexa Inc (Complexa) is a biopharmaceutical company that develops endogenous human cell signalling treatments for fibrosis and inflammation related diseases. The company’s lead product candidate products includes CXA-10 is an endogenous nitro fatty acid that modulates the human body’s mai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆